Helping Universities Avoid The Pitfalls Of Biotech Spin-offs
VCs And Tech Transfer Offices Team Up
Universities and venture capital firms have produced guidance that they hope will accelerate and support the founding of a new generation of start-ups.
You may also be interested in...
Cash Injection Puts Quell At Forefront Of Treg Therapy
The London-based biotech is hoping to turn the dream of liver organ transplant without the need for lifelong immunosuppression into reality.
Partner Or Go It Alone? TG Therapeutics Ponders EU Plans For Briumvi
TG Therapeutics has successfully launched Briumvi on its own in the US, despite fierce competition from established same-class MS drugs Ocrevus and Kesimpta, but is still weighing up the pros and cons of partnering for the European market.
Cosentyx Becomes First Biologic Approved For HS In Nearly A Decade
The Swiss major should have a considerable first-to-market advantage over other IL-17 biologics from the likes of UCB and Acelyrin that are also targeting the hidradenitis suppurativa space.